Skip to content

A single-center, randomized, controlled study of the combination of tonifying the kidneys, relieving dampness and resolving blood stasis formula with weight loss in the treatment of obese polycystic ovary syndrome with insulin resistance

A single-center, randomized, controlled study of the combination of tonifying the kidneys, relieving dampness and resolving blood stasis formula with weight loss in the treatment of obese polycystic ovary syndrome with insulin resistance

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006708
Enrollment
Unknown
Registered
2022-10-25
Start date
2022-10-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

Chinese medicine group:Tonifying the kidney, relieving dampness and resolving blood stasis formula combined with medical weight loss

Sponsors

Shenzhen Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. conform to Chinese or Western diagnosis of polycystic ovary syndrome with insulin resistance. 2. Women aged 20-40 years with no pregnancy plan in the future 6 months. 3. Body mass index (BMI) = weight/height^2 (kg/m^2) >= 24. 4. Voluntary participation and signed informed consent. 5. have the ability to use a smartphone to cooperate with medical weight loss online guidance and follow-up. 6. If using hormonal medication, the medication should be stopped for more than 3 months.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the inclusion criteria or do not take the drug as prescribed or have poor compliance. 2. Patients who are participating in clinical trials of other drugs. 3. Have recently taken hormonal drugs or other western drugs 4. Have obvious organic lesions or malformations of the reproductive system, or serious systemic diseases such as cardiovascular, endocrine, liver, kidney and hematopoietic system and other important organ lesions and psychiatric patients, as confirmed by examination test measurements.

Design outcomes

Primary

MeasureTime frame
Ovulation rates;weight;

Secondary

MeasureTime frame
FSH/LH/E2/PRL/T;Waist/hip circumference;fasting insulin;fasting blood sugar;

Countries

China

Contacts

Public ContactXuelian Du

Shenzhen Traditional Chinese Medicine Hospital

jndxl@hotmail.com+86 15919778851

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026